Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.98 USD | +4.08% | +11.38% | +76.49% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.49% | 1.93B | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+1.14% | 22.42B | |
-14.50% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Transcript : Aeglea BioTherapeutics, Inc. - Special Call